Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05242393 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 8, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: May 30, 2024 to Jan 30, 2026
    • Study completion date: Jul 31, 2024 to Dec 31, 2026
    v4
  2. 2 versions Re-verified since Feb 13, 2023, no change to tracked fieldsv2-v3
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.
Trial Details
NCT Number NCT05242393
Lead Sponsor Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Conditions
(from sponsor)		 Stroke, Ischemic, Sleep Disorder
Related terms Cognitive Dysfunction, Ischemic Stroke, Sleep Apnea Syndromes, Sleep Wake Disorders
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov